Delivery Order SPE2DB22D3501-SPE2DB23FVJ37
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,792.08, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $48,734.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of IBRANCE 100 MG CAPSULE 21S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $16,131.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $16,236.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IBRANCE 125 MG CAPSULE 21S. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 7, 2025. This award is not associated with a set-aside program and appears to be part of Amerisourcebergen's broader contract vehicle with the DLA, worth up to $999,999,999.00, which provides...
- This federal contract award, valued at $7,796.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IBRANCE 100 MG CAPSULE 21S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables DLA to efficiently procure a wide range of essential pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) has awarded a $7,792.08 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,592.62, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract award, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,061.38 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $8,061.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with an ultimate completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FVJ37Delivery Order
This federal contract award, valued at $14,973.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of IBRANCE 100 MG CAPSULE 21S, with a completion date of May 10, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 4/19/23 |